SCHEMBL3405080

SCHEMBL3405080

CC(C)C(C)(O)C(C)C.COCC(C)(C)O

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.32
ALDH1A1 P00352 2/20 0.30
CYP2C19 P33261 1/20 0.30
PIK3CD O00329 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38183 0.84
SCHEMBL4266363 0.81 ALDH1A1 (0.39) ALDH1A1
SCHEMBL6015163 0.81
SCHEMBL6015087 0.81
SCHEMBL5477839 0.81
SCHEMBL16566929 0.81 ALDH1A1 (0.39) ALDH1A1
Alcohol SCHEMBL4665688 0.76 ALDH1A1 (0.35) ALDH1A1
SCHEMBL3405084 0.74
SCHEMBL1245809 0.74
SCHEMBL17676146 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9125808-B2 Ionic silicone hydrogels JOHNSON & JOHNSON VISION CARE, INC. (US) 2015-09-08 US disclosed
US-20130217620-A1 IONIC SILICONE HYDROGELS JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-08-22 US disclosed
EP-2252443-A1 METHODS AND SYSTEMS FOR PROCESSING SILICONE HYDROGEL OPHTHALMIC LENSES FOR IMPROVED LENS TRANSFER Johnson & Johnson Vision Care, Inc. (US) 2010-11-24 EP disclosed
WO-2009108349-A1 METHODS AND SYSTEMS FOR PROCESSING SILICONE HYDROGEL OPHTHALMIC LENSES FOR IMPROVED LENS TRANSFER JOHNSON & JOHNSON VISION CARE, INC. (US) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217620-A1 IONIC SILICONE HYDROGELS HACD2, IGFBP2, IGFBP6 MAPK1 421/4885ALDH1A1 3613/4885CYP2C19 1143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.